baber/WOPTO huggingface dataset:
Patent AU-716555-B2 (AU)
Title: Branching connector for an underground cable
Inventor: FRANCOIS PIERRE
IPC: H01R4/24
Filed: 1997-01-28
Granted: 2000-03-02
Abstract: PCT No. PCT/FR97/00162 Sec. 371 Date Jul. 27, 1998 Sec. 102(e) Date Jul. 27, 1998 PCT Filed Jan. 28, 1997 PCT Pub. No. WO97/28578 PCT Pub. Date Aug. 7, 1997A branch connector for an underground cable enabling a main cable to be electrically connected to at least one branch cable, each being constituted by a metal core surrounded by an insulating sheath, and comprising a lower body (10) and an upper body (12) disposed facing each other and movable towards each other by clamping, each body including a contact element (16, 18; 50) which is made, at least in part, of metal and which is situated in a plane extending transversely relative to an axial direction of the cables and penetrating both through the insulation of the main cable and through the insulation of the branch cable to make contact with the cores of said cables when the upper and lower bodies are moved towards each other by at least one clamping means (14), and a movable non-conductive separator member (70) situated in the midplane of the connector and designed to enable two branch cables to be assembled without coming into contact with each other.
Patent AU-655256-B2 (AU)
Title: Lumbar support adjustment device
Inventor: LANCE MARK ANDREW
IPC: A47C7/46
Filed: 1992-03-26
Granted: 1994-12-08
Abstract: A lumbar support adjustment device is disclosed comprising a bracket (11) adapted to slidably restrain a lumbar support belt means (13) adapted to extend between first (12) and second (12') side frames of a seat, said bracket being adapted to be secured to the first side frame and having associated cam means (16) operable to slidably move said belt means between a first and a second position to provide lumbar support adjustment in which said cam means cooperates directly with cam follower means formed in or on said belt means.
Patent AU-602222-B2 (AU)
Title: Kaolinite aggregation using organo-silicon compounds
Inventor: RAYTHATHA RASIK H
IPC: D21H19/00
Filed: 1988-06-23
Granted: 1990-10-04
Abstract: A particulate kaolin pigment which enhances gloss and printability properties when used as a coating pigment for paper and enhances light scattering and opacifying properties when incorporated as a filler in paper, is obtained by mixing a fine particle kaolin with an aggregating agent comprising an organic silicon compound such as tetramethoxy silane or tetraethoxy silane.
Patent AU-624339-B2 (AU)
Title: A vaccine for protecting dogs against canine coronavirus
Inventor: BORDT DALE
IPC: A61K39/12
Filed: 1988-09-26
Granted: 1992-06-11
Abstract: Sterile pharmaceutical compositions for use in therapy especially inactivated vaccines for use in prophylaxis, are prepared by inactivating a live virus or bacterium with ascorbic acid and/or a salt thereof in the presence of oxygen and a source of heavy metal ions. Methods of treating animals, including humans, with such compositions are also disclosed.
Patent AU-746825-B2 (AU)
Title: Costimulatory blockade and mixed chimerism in allotransplantation
Inventor: SYKES MEGAN
IPC: A61K38/095
Filed: 1999-02-04
Granted: 2002-05-02
Abstract: Use of blockade of costimulation and hematopoietic stem cell transplantation in the promotion of graft acceptance.
Patent AU-773735-B2 (AU)
Title: Micronized freeze-dried particles
Inventor: MATHIOWITZ EDITH
IPC: A61K47/32
Filed: 2001-01-12
Granted: 2004-06-03
Abstract: A process is provided for making dry, micronized particles of an agent, such as a drug. The method includes (a) dissolving a macromolecular material, preferably a polymer, in an effective amount of solvent, to form a solution; (b) dissolving or dispersing the agent in the solution to form a mixture; (c) freezing the mixture; and (d) drying by vacuum the mixture to form solid particles of the agent dispersed in solid macromolecular material. The micronization in this process occurs directly in a macromolecular matrix and hardening of the particles of agent by solvent removal takes place by lyophilization of the bulk matrix, which stabilizes the drug particles during hardening and prevents coalescence, thereby resulting in a smaller final drug particles. The method is particularly preferred for protein agents. The process can be used in conjunction with a standard microencapsulation technique, typically following separation of the agent from the macromolecular matrix. The process yields microparticles having a homogenous size distribution, preferably less than 2  mu m, and more preferably less than 1  mu m, in size. The microparticles have well defined, predictable properties, which is particularly critical in drug delivery applications.
Patent AU-607046-B2 (AU)
Title: Alumina hydrate-containing toothpaste
Inventor: EVANS KENNETH ARTHUR
IPC: A61Q11/00
Filed: 1989-02-13
Granted: 1991-02-21
Abstract: This invention relates to toothpaste containing an alumina hydrate abrasive and flavouring. According to the invention, there is provided a toothpaste containing flavouring and unmilled, precipitated alumina trihydrate as an abrasive, wherein the alumina trihydrate particles have a median particle size of at least 3 micrometres. The median particle size of the alumina trihydrate is preferably below 30 micrometres, more preferably from 5 to 20 micrometres, and most preferably 8 to 12 micrometres. It has been found that the use of an unmilled alumina trihydrate, obtained by precipitation, reduces the amount of flavouring material required to obtain a given flavour strength when compared with an equivalent content of milled alumina trihydrate of similar particle size.
Patent AU-780134-B2 (AU)
Title: Gel powder composition
Inventor: SCORDAMAGLIA-CROCKETT BARBARA
IPC: A61K8/00
Filed: 2000-03-08
Granted: 2005-03-03
Abstract: The present invention relates to a liquid powder composition comprising a cosmetically acceptable base, and a powder component containing at least one cosmetically acceptable spherical microparticle. Preferably, the composition is an aqueous gel comprising polyurethane and silicone resin microparticles, combined with a starch, such as tapioca or corn starch.
Patent AU-668719-B2 (AU)
Title: Process for preparing methylolhydantoins
Inventor: FARINA THOMAS E
IPC: C07B61/00
Filed: 1993-05-20
Granted: 1996-05-16
Abstract: There are provided methods for producing solid anhydrous methylolhydantoins. Initially, an aqueous stirrable medium is dehydrated and heated to yield a substantially anhydrous stirrable melt. The aqueous stirrable medium includes (A) a solute selected from the group consisting of (i) a dimethyloldimethylhydantoin, (ii) a hydantoin reactant, (iii) a formaldehyde source reactant, or (iv) a combination of any of the foregoing; and (B) optionally a catalyst. A molten system is then provided by adding, to the stirrable melt, a reactant mixture which includes (A)(i) the same or a different hydantoin reactant, (ii) a substantially anhydrous formaldehyde source reactant which may be the same as or different than the formaldehyde source reactant, or (iii) a combination thereof; and (B) optionally, the same or a different catalyst; wherein the molten system includes (i) at least one hydantoin reactant and (ii) at least one dehydrated formaldehyde source reactant or substantially anhydrous formaldehyde source reactant. The at least one hydantoin reactant and the at least one dehydrated formaldehyde source reactant or substantially anhydrous formaldehyde source reactant in the molten system are reacted, while reaction water is removed, to yield anhydrous molten methylolhydantoin. Finally, the molten methylolhydantoin is solidified. Alternatively, solid anhydrous methylolhydantoin is produced by reacting, in an aqueous stirrable medium as above, a reactant mixture of (i) the same or a different hydantoin reactant, (ii) a substantially anhydrous formaldehyde source reactant which may be the same as or different than the formaldehyde source reactant, or (ii) a combination thereof and (iv) optionally, the same as or different catalyst; wherein (i) at least one hydantoin reactant and (ii) at least one formaldehyde source reactant or substantially anhydrous formaldehyde reactant is present; while heating to at least the melting temperature of the methylolhydantoin and while removing substantially all water; to yield a molten methylolhydantoin; and subsequently solidifying the molten methylolhydantoin. These methods can be practiced as batch processes or as semi-continuous processes.
Patent AU-744715-B2 (AU)
Title: Culture medium for culture of animal cell and method for producing protein using same
Inventor: SHIBUYA KAZUSHI
IPC: C12N5/02
Filed: 1999-06-01
Granted: 2002-02-28
Abstract: A culture medium for culture of an animal cell, characterized by containing an enzymatic degradation product of fish meat or a fish meat extract, and a method for producing a desired protein with the use of the culture medium.
Patent AU-636116-B2 (AU)
Title: Improved electroconductive composition and process of preparation
IPC: C09C3/06
Filed: 1989-09-14
Granted: 1993-04-22
Abstract: An electroconductive particulate composition comprising a particulate core having a surface coating comprising a silica-containing material or hydroxylated amorphous silica and a conductive layer comprising a two dimensional conducting network of antimony-containing tin oxide crystallites.
Patent AU-734515-B2 (AU)
Title: A short-shafted adenoviral fiber and its use
Inventor: WICKHAM THOMAS J
IPC: C12N7/01
Filed: 1997-08-21
Granted: 2001-06-14
Abstract: The present invention provides a short-shafted adenoviral fiber, a recombinant adenovirus comprising a short-shafted fiber, a vector comprising a short-shafted adenoviral fiber gene, and a method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
Patent AU-710581-B2 (AU)
Title: A ready-to-use urinary catheter assembly
Inventor: KAYEROD HELLE
IPC: A61M25/08
Filed: 1997-09-18
Granted: 1999-09-23
Abstract: A urinary catheter assembly comprises a urinary catheter (1) having on at least a part of its surface a hydrophilic surface layer (6) intended to produce a low-friction surface character of the catheter by treatment with a liquid swelling medium prior to use of the catheter and a catheter package (7) having a cavity (11) for accommodation of the catheter (1).  The package (7) includes a compartment (12) having walls of a gas impermeable material and accommodating said liquid swelling medium or a catheter pretreated therewith for long time preservation of said low-friction surface character and provision of a ready-to-use catheter assembly.
Patent AU-729457-B2 (AU)
Title: Delivery of therapeutic gene products by intestinal cell expression
Inventor: GERMAN MICHAEL
IPC: C12N15/09
Filed: 1997-09-18
Granted: 2001-02-01
Abstract: Intestinal epithelial cells of a mammalian subject are genetically altered to operatively incorporate a gene which expresses a protein which has a desired therapeutic effect. Intestinal cell transformation is accomplished by administration of a formulation containing DNA and is preferably administered orally. Oral or other intragastrointestinal routes of administration provide a simple method of administration. The expressed protein is secreted directly into the gastrointestinal tract and/or bloodstream to obtain therapeutic blood levels of the protein, thereby treating the patient in need of the protein. The delivery system of the invention provides short or long term delivery of therapeutic gene products.
Patent AU-746769-B2 (AU)
Title: Methods and apparatus for the production of amorphous polymer suspensions
Inventor: HOROWITZ DANIEL
IPC: C08F2/16
Filed: 1999-06-09
Granted: 2002-05-02
Abstract: Methods and apparati have been developed for producing a suspension of predominately amorphous polymer particles, wherein the method includes thermally treating a suspension that includes crystalline or semi-crystalline polymer particles. The thermal treatment includes (a) heating a suspension of polymer particles of an appropriate size to a temperature effective to cause the polymer to become amorphous, and then (b) cooling the suspension of amorphous polymer particles below the melting point of the polymer at a rate effective to prevent substantial coalescence of the polymer particles. The method and apparati are effective for use with a variety of polymers having suitable crystallization parameters, although polyhydroxyalkanoate (PHA) polymers are preferred, particularly in an aqueous suspension medium. For PHA polymers, the polymer particles subjected to treatment preferably are of a size of less than 5 mum, or more preferably less than 1.5 mum in diameter.
Patent AU-618430-B2 (AU)
Title: New serineprotease inhibitor proteins, pharmaceutical compositions containing them, dna sequences coding for these proteins and processes for the preparation of these proteins, pharmaceutical compositions and dna sequences
Inventor: HEINZEL-WIELAND REGINA
IPC: C12N15/15
Filed: 1989-12-07
Granted: 1991-12-19
Abstract: The invention relates to serine protease inhibitor proteins, medicaments containing them, DNA sequences coding for these proteins and methods for producing these proteins, medicaments and DNA sequences. These proteins correspond to the formula <IMAGE> or sections thereof which comprise at least the sequence of positions 53-101, in which W is tyrosine or glutamic acid, X1, X2 and X3 are identical or different and each of these radicals is methionine or leucine, it also being possible for X3 to be phenylalanine, Y is proline or arginine, and Z is leucine or, if W is tyrosine and X1, X2 and X3 are leucine, is also isoleucine, and fusion proteins of these serine protease inhibitor proteins. The proteins are particularly distinguished by a strong inhibitory action against human leukocyte elastase and pronounced stability to oxidative breakdown. DNA sequences which code for the serine prolease inhibitor proteins and the expression of these proteins in suitable host organisms by means of various vectors, and the isolation of these proteins in pure biologically active form, and medicaments containing these products, are described. <IMAGE> (Oligonucleotid = oligonucleotide> Figure 1a: DNA oligonucleotides D11, D12, D13, D11a, D12a and D13a (listed in the 3'->5' direction of synthesis) which are used in the synthesis of the DNA sequence "ALP gene 230" (Figure 2a). <IMAGE> Figure 1b: DNA oligonucleotides D21, D22, D23, D21a, D22a and D23a (listed in the 3'->5' direction of synthesis) which are used in the synthesis of the DNA sequence "ALP gene 230" (Figure 2a). <IMAGE> Figure 1c: DNA oligonucleotides D24, D25, D24a and D25a (listed in the 3'->5' direction of synthesis) which are used in the synthesis of the DNA sequence "ALP gene 240" (Figure 2b) commencing from the DNA sequence ALP gene 230.
Patent AU-629492-B2 (AU)
Title: Electric motor
Inventor: KAWAI TERUO
IPC: H02K41/06
Filed: 1989-12-28
Granted: 1992-10-01
Abstract: An electric motor comprises a plurality of electromagnets (1a, 1b ....) arragned annularly in parallel, an electric switching circuit (8) connected to each electromagnet (1a, 1b ....), an iron cylinder (4) arranged inside the electromagnets (1a, 1b ....) and having peripheral surface to be attracted partially arbitrarily by part of the electromagnets (1a, 1b ....), a main axle (5a) positioned at the center of the iron cylinder (4) and coaxially arranged with an axial core of the iron cylinder (4) via bearings (6, 7), and eccentric axles (5b, 5b) provided at both ends of the main axle (5a) so that the eccentric axles (5b, 5b) are arranged in accord with the center of the electromagnets (1a, 1b ....) to define a power generating axle.
Patent AU-517264-B2 (AU)
Title: Pivoted flap photocopier toner level indicator
Inventor: KLEINSCHMIDT W
IPC: G01F23/00
Filed: 1979-06-14
Granted: 1981-07-16
Abstract: Apparatus is disclosed for determining the quantity of particles present in a container. A sensor device is movably mounted in the container and is in contact with the particles. When the filling height in the container falls below a predetermined value, an electrical switch is actuated and emits a signal to an indicator. The sensor device comprises a flap fixed on an axle rotatably mounted in the container. A resilient element presses the flap against the quantity of particles and a cam is mounted on the axle. On rotation of the axle, the cam actuates the electrical switch.
Patent AU-669003-B2 (AU)
Title: Improved sustained energy and anabolic composition
Inventor: PAUL STEPHEN M
IPC: A23L1/305
Filed: 1993-07-22
Granted: 1996-05-23
Abstract: A composition which provides for sustained energy and nutrition to support an anabolic physiological state in humans comprises a blend of simple sugars and more complex carbohydrates, partially hydrolyzed protein, and, at least, magnesium in the form of an amino acid chelate. Preferably the carbohydrate source is a blend of about 5-45% crystalline fructose and 55-95% glucose polymers by weight. Other ingredients, including lipids, bioavailable minerals in the form of amino acid chelates, anabolic nutrients, vitamins, antioxidants, and lipotropic agents may be added as desired to provide an optimal sustained energy and anabolic nutrition formulation. When administered, the carbohydrate blend, protein source, and amino acid chelates facilitate sustained energy and delivery of nutrients to appropriate sites within the body for efficient utilization in anabolic physiology.
Patent AU-784007-B2 (AU)
Title: Inhibitors of dipeptidyl peptidase IV
Inventor: EVANS DAVID MICHAEL
IPC: A61P37/02
Filed: 2001-04-26
Granted: 2006-01-12
Abstract: Compounds according to formula (1), wherein R<SUP>1 </SUP>is H or CN, X<SUP>1 </SUP>is S, O, SO<SUB>2 </SUB>or CH<SUB>2</SUB>, X<SUP>2 </SUP>is CO, CH<SUB>2 </SUB>or a covalent bond, Het is a nitrogen-containing heterocycle and n is 1-5 are new. The compounds of the invention are inhibitors of dipeptidyl peptidase IV. Pharmaceutical compositions of the compounds of the invention, or pharmaceutically acceptable salts thereof, are useful in the treatment of, inter alia, type 2 diabetes
Patent AU-578783-B2 (AU)
Title: Pyridopyrimidines, several processes for their preparation and their use as medicaments
Inventor: MEYER HORST
IPC: A61K31/505
Filed: 1986-01-10
Granted: 1988-11-03
Abstract: Pyridopyrimidines of the formula   <IMAGE>   in which R1 is optionally substituted aryl or heterocyclic, exhibit circulation active properties, especially renal vasodilating and diuretic action.
Patent AU-599582-B2 (AU)
Title: A d-amino acid oxidase and method for isolation thereof
Inventor: MOSBACH KLAUS
IPC: C12N9/06
Filed: 1986-01-10
Granted: 1990-07-26
Abstract: A Trigonopsis variabilis D-amino acid oxidase in substantially pure form and active against cephalosporin C. This D-amino acid oxidase is isolated from Trigonopsis variabilis by a method which is performed in three steps, namely: (a) acidifying and heating a crude cell extract of Trigonopsis variabilis to obtain a precipitate and supernatant fraction; (b) treating said supernatant fraction obtained in step (a) with sufficient ammonium sulfate to obtain a second precipitate, said second precipitate containing the D-amino acid oxidase of claim 1; and (c) resuspending the precipitate obtained in step (b) and collecting the D-amino acid oxidase by isoelectric precipitation.
Patent AU-524176-B2 (AU)
Title: Pasteurised intermediate moisture foods
Inventor: BRIMELOW CHRISTOPHER
IPC: A23L3/34
Filed: 1979-11-27
Granted: 1982-09-02
Abstract: Pasteurised food prod. of intermediate moisture content has water activity 0.86-0.91, and pH 4.5-5.5 and is pasteurised in packages which are hermetically sealed before, during or immediately after pasteurising. The specified water activity is achieved by drying the prod. (or one or more of its ingredients) and/or by incorporating a humectant. pref. a sugar, salt, polyol and/or water soluble acid. Pref. humectants are glycerol, sucrose, glucose, polypropylene glycol, NaCl and/or sorbitol. The pH is pref. adjusted with acetic, citric, lactic, malic or tartaric acids, glucono-delta-lactone or acidic Na pyrophosphate. The prods. have long-term storage stability without refrigeration. Compared with prods. of lower water activity they have superior quality (esp. because less humectant is needed); better heat exchange properties when reheated; and do not require addition of antimycotics.
Patent AU-618896-B2 (AU)
Title: Stable solutions of rebeccamycin analog and preparation thereof
Inventor: BOGARDUS JOSEPH B
IPC: C07C55/10
Filed: 1990-05-09
Granted: 1992-01-09
Abstract: Stable solutions of rebeccamycin analog consist essentially of (a) water, (b) 8-N-(diethylaminoethyl)rebeccamycin in an effective dosage amount, and (c) pharmaceutically acceptable acid such that the presence of a molar equivalence thereof would solubilize (b), said acid being present in excess of said molar equivalence to provide a stabilizing pH ranging from 3 to 4, preferably from 3.0 to 3.6. A preferred solution contains 10 mg/ml of the free base and tartaric acid in equimolar amount with the free base to provide a pH of 3.5. Preferably, the solution is prepared by forming a suspension of 8-N-(diethylaminoethyl)rebeccamycin in water and adding acid to provide a pH ranging from 3 to 4.
Patent AU-742355-B2 (AU)
Title: Monitoring control device with real time data sampling for machine used in the cable industry
Inventor: MICHNIK YVES
IPC: D07B7/14
Filed: 1998-01-08
Granted: 2002-01-03
Abstract: The monitoring and control device with real time data sampling comprises an optical measuring apparatus, a processing circuit with microprocessor, and an external control means. The microprocessor receives and samples data coming from the optical measuring apparatus to know the position of the wire element and its mechanical vibration behavior in real time before it is wound onto the main cable. An EPROM memory is programmed to generate a self-correction function should a drift of the position and vibration data of the wire element occur. The first motor, the second motor, and the mechanical tensioning means are controlled to re-establish optimum operation of the assembly machine.
Patent AU-725730-B2 (AU)
Title: Interactive, predictive game control system
Inventor: WESTON DAVID ROBERT
IPC: H04N7/173
Filed: 1998-04-21
Granted: 2000-10-19
Abstract: An interactive, predictive game control system for use in conjunction with a live TV broadcast received by one or more remote players (C). The system comprises a central controller (1) for generating game playing data for transmission with a TV broadcast to the remote player(s) and for receiving information from the remote player(s). An input device (2) is connected to the central controller (1). A database (4A) is connected to the central controller (1) for storing data relating to the content of the live broadcast and known in advance of the live broadcast. The central controller (1) is responsive to signals from the input device (2):   a) prior to the live broadcast, to select data from the database (4A) for transmission to the remote user(s) in advance of and/or during the live broadcast, and b) during or after the live broadcast, to record the time of occurrence of one or more events relating to the live broadcast which are to be predicted by the remote player(s), as indicated by an operator to the central controller (1) via the input device (2).   <IMAGE>
Patent AU-656720-B2 (AU)
Title: Production of recombinant polypeptides by bovine species and transgenic methods
Inventor: HEYNEKER HERBERT L
IPC: C12N15/87
Filed: 1990-11-30
Granted: 1995-02-16
Abstract: The invention provides a transgenic bovine species capable of producing a recombinant polypeptide in at least one cell type of said animal. Other aspects include transgenes for the production of such animals, milk resulting therefrom and the use of such milk and heterologous polypeptides contained within such milk.